Details of the Optogenetic System
| General Information of This Optogenetic System (OS) | ||||||
|---|---|---|---|---|---|---|
| OS ID |
OS00634
|
|||||
| OS Name |
Optogenetic bispecific T-cell engagers
(OptoBiTEs)
|
[1] | ||||
|
Photoreceptor (PR) |
|
|||||
| Cofactor | Biliverdin (BV) | |||||
| Controlled Protein | Fusion protein | Putative DNA binding protein | ||||
| The bacterial c-di-GMP phosphodiesterase | ||||||
| OS Application Information (1) | ||||||
|---|---|---|---|---|---|---|
| Mechanism of Action | c-di-GMP synthesis | [ 1] | ||||
| Controlled Signal Pathway | Gene expression | |||||
| Effect | Activation | |||||
| Application | Optogenetics can regulate the production of BiTEs from bioengineered cells for the treatment of cancer | |||||
| Note | This method could be potentially applied to other formats of bispecific antibodies and facilitate their clinical applications | |||||
| Light Information | Activation Wavelength | Far-red Light | ||||
| Process | Reversible | |||||
| Deactivation Wavelength | Dark | |||||
| Activation Time | 24 h | |||||
| Light Intensity | 1 miliwatt per square centimeter | |||||
| Expression Information | Expression Method | Transfection | ||||
| Cell Lines | HEK293FT cells | |||||